Low-Dose Anthracycline and Risk of Heart Failure in a Pharmacokinetic Model of Human Myocardium Exposure: Analog Specificity and Role of Secondary Alcohol MetabolitesJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82018-02-0119OAAI
Modeling Human Myocardium Exposure to Doxorubicin Defines the Risk of Heart Failure from Low-Dose DoxorubicinJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82017-08-0119OAAI
Electrical Modeling of an Isolated Surgical Aortic Valve Replacement for Microshock Risk AssessmentIEEE TRANSACTIONS ON INDUSTRY APPLICATIONSIF4.52016-01-010PREAI
Simvastatin attenuates the endothelial pro-thrombotic shift in saphenous vein grafts induced by Advanced glycation endproductsTHROMBOSIS RESEARCHIF3.42014-03-0112PREAI
In Situ Electrostimulation Drives a Regenerative Shift in the Zone of Infarcted MyocardiumCELL TRANSPLANTATIONIF3.22013-03-015OAAI
The Novel Anthracenedione, Pixantrone, Lacks Redox Activity and Inhibits Doxorubicinol Formation in Human Myocardium: Insight to Explain the Cardiac Safety of Pixantrone in Doxorubicin-Treated PatientsJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82013-02-0153PREAI
Pharmacokinetic Characterization of Amrubicin Cardiac Safety in an Ex Vivo Human Myocardial Strip Model. I. Amrubicin Accumulates to a Lower Level than Doxorubicin or EpirubicinJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82012-05-0111PREAI
Pharmacokinetic Characterization of Amrubicin Cardiac Safety in an Ex Vivo Human Myocardial Strip Model. II. Amrubicin Shows Metabolic Advantages over Doxorubicin and EpirubicinJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82012-05-0128PREAI
Electrospun Hydroxyapatite-Functionalized PLLA Scaffold: Potential Applications in Sternal Bone HealingANNALS OF BIOMEDICAL ENGINEERINGIF5.42011-03-1539PREAI
Poly-l-Lactic Acid/Hydroxyapatite Electrospun Nanocomposites Induce Chondrogenic Differentiation of Human MSCANNALS OF BIOMEDICAL ENGINEERINGIF5.42009-05-06101PREAI
Doxorubicinolone Formation and Efflux: A Salvage Pathway against Epirubicin Accumulation in Human HeartJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82009-04-0122PREAI
Giant vegetation in prosthetic valve Candida albicans endocarditisEUROPEAN JOURNAL OF CARDIO-THORACIC SURGERYIF32008-08-013PREAI
Simvastatin reduces platelet-endocardium adhesion in atrial fibrillationATHEROSCLEROSISIF5.72008-04-0111PREAI
Dysphagia soon after off-pump coronary surgery: the single suture techniqueEUROPEAN JOURNAL OF CARDIO-THORACIC SURGERYIF32007-10-012PREAI
The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: A Randomized controlled studyCLINICAL THERAPEUTICSIF3.62007-08-0124PREAI
Response to letters regarding article, Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: Results of the ARMYDA-3 (Atorvastatin for reduction of myocardial dysrhythmia after cardiac surgery) studyCIRCULATIONIF38.62007-04-173OAAI
Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgeryANNALS OF THORACIC SURGERYIF3.92007-04-0190PREAI
Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery - Results of the ARMYDA-3 (Atorvastatin for reduction of MYocardial dysrhythmia after cardiac surgery) studyCIRCULATIONIF38.62006-10-03557OAAI
Effects of atorvastatin on systemic inflammatory response after coronary bypass surgeryCRITICAL CARE MEDICINEIF62006-03-01201PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向